脳脊髄液管理装置市場：製品、年齢層、エンドユーザー別-2025-2030年の世界予測

脳脊髄液管理装置市場は、2023年に17億3,000万米ドルと評価され、2024年には18億3,000万米ドルに達すると予測され、CAGR 6.05％で成長し、2030年には26億1,000万米ドルに達すると予測されています。

脳脊髄液（CSF）管理装置市場には、水頭症、頭蓋内圧亢進症、外傷性脳損傷など、さまざまな病状に不可欠な脳脊髄液の流入と排出に関連する障害を管理するために設計されたさまざまな製品が含まれます。これらの装置は、脳脊髄液の圧力と流量を調整することにより、中枢神経系の健康を維持する上で重要であり、主に神経学と脳神経外科で応用され、脳損傷のリスクを軽減し、患者の転帰を向上させる。最終用途は病院、脳神経外科クリニック、専門医療センターであることが多いです。髄液管理デバイスの必要性は、神経疾患の発生率の上昇、世界人口の高齢化、高度な治療オプションに対する意識の高まりによって高まっています。主な成長要因としては、医療技術の急速な発展、ヘルスケア支出の増加、既存機器の性能向上を目指した研究開発の活発化などが挙げられます。新たなビジネスチャンスは、センサー一体型シャントシステムや遠隔医療機能などのスマート技術を取り入れて、患者のモニタリングや装置の効率を高めることにあります。しかし、市場の限界としては、装置のコストが高いこと、操作に熟練した専門家が必要なこと、これらの装置に関連する外科的処置から生じる合併症の可能性があることなどが挙げられます。さらに、厳しい規制の枠組みや償還の課題が大きなハードルとなっています。技術革新は、費用対効果が高く低侵襲の機器を開発し、使いやすい機能によって患者のコンプライアンスを高めることに焦点を当てることができます。個別化医療のアプローチや、合併症を未然に防ぐためのAIを活用した予測分析の統合には大きな可能性があります。市場はダイナミックで、絶え間ない技術革新と激しい競合を特徴としているため、企業は戦略的提携や協力関係を重視し、市場への参入を拡大し、技術力を強化する必要があります。持続的な事業成長のためには、継続的な製品革新、患者教育プログラム、積極的な規制遵守を取り入れることで、市場への浸透を促進し、ブランドの信頼性を向上させることができます。

市場力学：急速に進化する脳脊髄液管理装置市場の主要市場インサイトを公開

脳脊髄液管理装置市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 老年人口の増加とライフスタイルの急速な変化
  • 神経疾患の世界の増加
  • 世界のヘルスケア支出の増加
• 市場抑制要因
  • 髄液シャントの使用に伴うデバイスの高コストと感染リスク
• 市場機会
  • 髄液排出の変化を正確に検出・調節するセンサー・システムの開発
  • 新しく革新的なシャントの研究開発の活発化
• 市場の課題
  • 髄液シャントの故障や誤作動に伴うリスク

ポーターのファイブフォース：脳脊髄液管理装置市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：脳脊髄液管理装置市場における外部からの影響の把握

外部マクロ環境要因は、脳脊髄液管理装置市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析脳脊髄液管理装置市場における競合情勢の把握

脳脊髄液管理装置市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス脳脊髄液管理装置市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、脳脊髄液管理装置市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨脳脊髄液管理装置市場における成功への道筋を描く

脳脊髄液管理装置市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢化人口の増加とライフスタイルの急速な変化
    • 神経疾患の発症率が世界的に増加
    • 世界中でヘルスケア費が増加
  • 抑制要因
    • 機器のコストが高く、髄液シャントの使用に伴う感染リスクがある
  • 機会
    • 脳脊髄液排出の変化を正確に検出し、制御するためのセンサーシステムの開発
    • 新しい革新的なシャントに関する研究開発活動の強化
  • 課題
    • 脳脊髄液シャントの故障や機能不全に伴うリスク
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 脳脊髄液管理装置市場：製品別

• CSF排水システム
  • 腰椎ドレナージシステム
  • 脳室ドレナージシステム
• 脳脊髄液シャント
  • 調節可能なCSFシャント
  • 固定式髄液シャント

第7章 脳脊髄液管理装置市場：年齢層別

• 成人用
• 高齢者
• 小児科

第8章 脳脊髄液管理装置市場：エンドユーザー別

• 外来手術センター
• クリニック
• 病院
• 神経センター

第9章 南北アメリカの脳脊髄液管理装置市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の脳脊髄液管理装置市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの脳脊髄液管理装置市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• B. Braun Melsungen AG
• BeckerSmith Medical, Inc.
• Bio-Rad Laboratories, Inc.
• Biogen Inc.
• bioMerieux, SA
• CereVasc, Inc.
• Delta Surgical Ltd.
• Enzo Biochem Inc.
• G. Surgiwear Ltd.
• Integra LifeSciences Corporation
• IRRAS AB
• Johnson & Johnson Services, Inc.
• Medtronic PLC
• MOLLER Medical GmbH
• Natus Medical Incorporated
• Neuromedex GmbH
• Penumbra, Inc.
• Shenzhen New Industries Biomedical Engineering Co., Ltd.
• Sinduri Biotec
• Sophysa SA
• Spiegelberg GmbH & Co. KG
• Stryker Corporation
• Terumo Corporation
• Trivitron Healthcare
• Wellong Instruments Co., Ltd.

LIST OF FIGURES

• FIGURE 1. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY LUMBAR DRAINAGE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY VENTRICULAR DRAINAGE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY ADJUSTABLE CSF SHUNTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY FIXED CSF SHUNTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY NEUROLOGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. CANADA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. CANADA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 43. CANADA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 44. CANADA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 45. CANADA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. CHINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. CHINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 70. CHINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 71. CHINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 72. CHINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. INDIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. INDIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 75. INDIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 76. INDIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 77. INDIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 159. ITALY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. ITALY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 161. ITALY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 162. ITALY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 163. ITALY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 179. POLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 180. POLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 181. POLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 182. POLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 183. POLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 184. QATAR CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 185. QATAR CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 186. QATAR CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 187. QATAR CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 188. QATAR CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 234. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 235. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Cerebrospinal Fluid Management Devices Market was valued at USD 1.73 billion in 2023, expected to reach USD 1.83 billion in 2024, and is projected to grow at a CAGR of 6.05%, to USD 2.61 billion by 2030.

The cerebrospinal fluid (CSF) management devices market encompasses a range of products designed to manage disorders related to the flow and drainage of cerebrospinal fluid, essential in various medical conditions including hydrocephalus, intracranial hypertension, and traumatic brain injuries. These devices are critical in maintaining CNS health by regulating CSF pressure and flow, with applications primarily in neurology and neurosurgery to mitigate risks of brain damage and enhance patient outcomes. End-use scopes often involve hospitals, neurosurgery clinics, and specialized medical centers. The necessity of CSF management devices is accentuated by the rising incidence of neurological disorders, an aging global population, and growing awareness of advanced treatment options. Key growth factors include the rapid advancements in medical technology, increasing healthcare expenditure, and escalated research and development efforts aimed at improving existing device performance. Emerging opportunities lie in embracing smart technologies, such as sensor-integrated shunt systems and telemedicine capabilities, to enhance patient monitoring and device efficiency. However, market limitations include high costs of devices, the need for skilled professionals for operation, and potential complications arising from surgical procedures related to these devices. Moreover, stringent regulatory frameworks and reimbursement challenges pose significant hurdles. Innovation could focus on developing cost-effective and minimally invasive devices, as well as enhancing patient compliance through ease-of-use features. There's substantial potential in personalized medicine approaches and integrating AI-enabled predictive analytics to preempt complications. The market is dynamic, characterized by constant technological innovations and intensive competition, necessitating companies to focus on strategic partnerships and collaborations to expand market reach and enhance technological capabilities. For sustained business growth, embracing continuous product innovation, patient education programs, and proactive regulatory compliance can facilitate deeper market penetration and improved brand credibility.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cerebrospinal Fluid Management Devices Market

The Cerebrospinal Fluid Management Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing geriatric population and rapidly changing lifestyle
  • Global increase in the incidence of neurological diseases
  • Rising healthcare expenditure across the world
• Market Restraints
  • High cost of devices and risk of infection with the usage of CSF shunts
• Market Opportunities
  • Development of sensor systems for accurate detection and regulation of changes in CSF drainage
  • Increasing research and development activities for new and innovative shunts
• Market Challenges
  • Risks associated with the failure and malfunctioning of CSF shunts

Porter's Five Forces: A Strategic Tool for Navigating the Cerebrospinal Fluid Management Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cerebrospinal Fluid Management Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cerebrospinal Fluid Management Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cerebrospinal Fluid Management Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cerebrospinal Fluid Management Devices Market

A detailed market share analysis in the Cerebrospinal Fluid Management Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cerebrospinal Fluid Management Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cerebrospinal Fluid Management Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cerebrospinal Fluid Management Devices Market

A strategic analysis of the Cerebrospinal Fluid Management Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cerebrospinal Fluid Management Devices Market, highlighting leading vendors and their innovative profiles. These include B. Braun Melsungen AG, BeckerSmith Medical, Inc., Bio-Rad Laboratories, Inc., Biogen Inc., bioMerieux, SA, CereVasc, Inc., Delta Surgical Ltd., Enzo Biochem Inc., G. Surgiwear Ltd., Integra LifeSciences Corporation, IRRAS AB, Johnson & Johnson Services, Inc., Medtronic PLC, MOLLER Medical GmbH, Natus Medical Incorporated, Neuromedex GmbH, Penumbra, Inc., Shenzhen New Industries Biomedical Engineering Co., Ltd., Sinduri Biotec, Sophysa SA, Spiegelberg GmbH & Co. KG, Stryker Corporation, Terumo Corporation, Trivitron Healthcare, and Wellong Instruments Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Cerebrospinal Fluid Management Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across CSF Drainage Systems and CSF Shunts. The CSF Drainage Systems is further studied across Lumbar Drainage System and Ventricular Drainage System. The CSF Shunts is further studied across Adjustable CSF Shunts and Fixed CSF Shunts.
• Based on Age Group, market is studied across Adult, Geriatric, and Pediatric.
• Based on End User, market is studied across Ambulatory Surgical Centers, Clinics, Hospitals, and Neurological Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing geriatric population and rapidly changing lifestyle
    • 5.1.1.2. Global increase in the incidence of neurological diseases
    • 5.1.1.3. Rising healthcare expenditure across the world
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of devices and risk of infection with the usage of CSF shunts
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of sensor systems for accurate detection and regulation of changes in CSF drainage
    • 5.1.3.2. Increasing research and development activities for new and innovative shunts
  • 5.1.4. Challenges
    • 5.1.4.1. Risks associated with the failure and malfunctioning of CSF shunts
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cerebrospinal Fluid Management Devices Market, by Product

• 6.1. Introduction
• 6.2. CSF Drainage Systems
  • 6.2.1. Lumbar Drainage System
  • 6.2.2. Ventricular Drainage System
• 6.3. CSF Shunts
  • 6.3.1. Adjustable CSF Shunts
  • 6.3.2. Fixed CSF Shunts

7. Cerebrospinal Fluid Management Devices Market, by Age Group

• 7.1. Introduction
• 7.2. Adult
• 7.3. Geriatric
• 7.4. Pediatric

8. Cerebrospinal Fluid Management Devices Market, by End User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Clinics
• 8.4. Hospitals
• 8.5. Neurological Centers

9. Americas Cerebrospinal Fluid Management Devices Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Cerebrospinal Fluid Management Devices Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Cerebrospinal Fluid Management Devices Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. B. Braun Melsungen AG
• 2. BeckerSmith Medical, Inc.
• 3. Bio-Rad Laboratories, Inc.
• 4. Biogen Inc.
• 5. bioMerieux, SA
• 6. CereVasc, Inc.
• 7. Delta Surgical Ltd.
• 8. Enzo Biochem Inc.
• 9. G. Surgiwear Ltd.
• 10. Integra LifeSciences Corporation
• 11. IRRAS AB
• 12. Johnson & Johnson Services, Inc.
• 13. Medtronic PLC
• 14. MOLLER Medical GmbH
• 15. Natus Medical Incorporated
• 16. Neuromedex GmbH
• 17. Penumbra, Inc.
• 18. Shenzhen New Industries Biomedical Engineering Co., Ltd.
• 19. Sinduri Biotec
• 20. Sophysa SA
• 21. Spiegelberg GmbH & Co. KG
• 22. Stryker Corporation
• 23. Terumo Corporation
• 24. Trivitron Healthcare
• 25. Wellong Instruments Co., Ltd.